First Trust Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.6M Buy
+649,127
New +$4.65M 0.01% 1224
2025
Q2
– Sell
-84,397
Closed -$281K – 2649
2025
Q1
$281K Sell
84,397
-239,849
-74% -$1.24M ﹤0.01% 2384
2024
Q4
$2.4M Buy
+324,246
New +$3.01M ﹤0.01% 1730

Other funds holding IOVA

First Trust Advisors's IOVA Position: Q3 2026 in Review

First Trust Advisors opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 649,127 shares worth $9.6M. The stake represents 0.01% of the portfolio and ranks #1224 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in IOVA as recently as Q1 2025.

First Trust Advisors first reported a position in IOVA in Q4 2024 and has held it in 3 quarters since. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • First Trust Advisors held 649,127 shares of Iovance Biotherapeutics worth $9.6M as of Q3 2026.
  • Iovance Biotherapeutics was a new First Trust Advisors position in Q3 2026.
  • Iovance Biotherapeutics made up 0.01% of First Trust Advisors's portfolio in Q3 2026, its #1224 holding.
  • First Trust Advisors first reported a position in Iovance Biotherapeutics in Q4 2024 and has held it in 3 quarters since.
  • 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.